Hull York Medical School - Chair in Neuroscience

The Hull York Medical School is seeking candidates for a full
Professorship in Neuroscience

full details can be obtained from
http://www.hyms.ac.uk/jobs/leading_researchers.aspx

This post is part of a strategic plan to develop a research portfolio
within the newly formed HYMS Centre for Neuroscience, one of five
interactive and dynamic centres within the Medical School. The
successful candidate for this post will have an outstanding research
record demonstrating their commitment to research, innovative
leadership, teaching and learning. He or she will be expected to exploit
the considerable opportunities for collaborative research with
colleagues and existing research teams in the Universities of Hull and York.

The individual will have a specific remit to complement and enhance the
research activities of the Wellcome-Wolfson Centre for Hyperpolarisation
in MRI. The Centre is a new facility being developed within the
University of York. It has been formed to take a major advance in
molecular imaging from the bench to the bedside. The facility will house
state-of-the-art preclinical scanning facilities, NMR, DNP and extensive
synthetic and analytical chemistry capabilities, that support the
development of the use of nuclear spin hyperpolarisation in a wide range
of biomolecules, models of disease processes and eventually, in clinical
practice.

Candidates with expertise in the study of molecular or imaging
neuroscience are particularly encouraged to apply, although any research
programme that extends our current strengths of neuroscience, imaging
and chemistry would be considered. In addition to the development of a
research programme, the post holders will contribute to the teaching of
neuroscience and imaging science to undergraduate students studying
medicine and biomedical science.

Enquiries should be directed to Prof Tony Kendrick, Dean of HYMS,
email:Tony.Kendrick@hyms.ac.uk, Prof. Simon Duckett (Hyperpolarisation)
email sbd3@york.ac.uk, Prof Gary Green (Imaging) email
Gary.Green@york.ac.uk, or Prof Tony Morland (Neurosciences)
Antony.Morland@.york.ac.uk, can be approached with specific enquiries
about the current research environment.

Further details, including an outline Job description and Person
specification, are available in the briefing document.
http://www.hyms.ac.uk/jobs/HYMS_candidate_brief.pdf

How to Apply
If you are ambitious, and have the drive and ability to help us to
continue to develop as a top 10 medical school, we would be delighted to
hear from you. Applicants must have a higher degree (MD/PhD) in a
relevant subject as well as

    * Have significant experience of teaching and research in a higher
education setting;
    * Have a strong record of peer reviewed publications;
    * Have a strong record of successful competitive applications for
externally funded research including as Principal/Chief Investigator.


Salary will depend on the level of appointment, and whether clinical or
non-clinical.

The closing date for applications is 10 October 2011.

-- Gary Green

York Neuroimaging Centre
The Biocentre
York Science Park
Innovation Way
Heslington
York
YO10 5DG


http://www.ynic.york.ac.uk
https://www.ynic.york.ac.uk/about-us/people/ggrg

tel. +44 (0) 1904 435349
PA - Claire Fox :  +44 (0) 1904 435329  or Claire.Fox@ynic.york.ac.uk

fax  +44 (0) 1904 435356
mobile +44 (0) 788 191 3004

2010 World Molecular Imaging Congress

September 8-11, 2010 Kyoto, Japan at the International Conference Center

http://www.wmicmeeting.org/dev/

Plan to join us for WMIC 2010, which will be held September 8-11, 2010 in Kyoto, Japan. We will be meeting at the beautiful International Conference Center, which has been home to many conferences of global significance.

Like WMIC 2009, this year's program will be constructed primarily on the strength of submitted abstracts, and the Program Committee will be integrating many of these abstracts into special sessions that bring attendees from different disciplines together for a comprehensive examination of the role of molecular imaging in particular biomedical problems.

We are proud to announce our Keynote Speaker for the 2010 World Molecular Imaging Congress will be:


Shizuo Akira, M.D., Ph.D.

Shizuo Akira, M.D., Ph.D., (born January 27, 1953 in Higashiosaka) is a distinguished and highly cited professor at the Department of Host Defense, Osaka University, Japan. He has made ground-breaking discoveries in the field of immunology, especially in the area of innate host defense mechanisms.

Besides being one of the world’s most-cited scientists in 2006 and 2007, Dr. Akira was recognized as the scientist who had published the greatest number of “Hot Papers” over the preceding two years. He is the recipient of several international awards, including the Robert Koch Prize and the William B. Coley Award.

Among his greatest discoveries is the demonstration, through the ablation of toll-like receptor (TLR) genes, that TLRs recognize a discrete collection of molecules of microbial origin, and later the RNA helicases, RIG-I (retinoic-acid-inducible protein I) and MDA5 (melanoma differentiation-associated protein 5). All molecules belong to the pattern recognition receptors, which detect intruding pathogens and initiate anti-microbial responses in the host.


WMIC 2010 Steering Committee
June-Key Chung, MD, PhD, Secretary General of the Federation of Asian Societies for Molecular Imaging, Seoul National University Hospital, Korea
Johannes Czernin, MD, Immediate Past President of the Academy of Molecular Imaging, UCLA School of Medicine, Los Angeles, CA
Win-Ping Deng, Council Representative of the Federation of Asian Societies for Molecular Imaging, Taipei Medical University, Taiwan
Yasuhisa Fujibayashi, PhD, President of the Society for Molecular Imaging, University of Fukui, Japan
Andreas Jacobs, MD, President of the European Society for Molecular Imaging, Lab for Gene Therapy and Molecular Imaging, Germany
Clemens Lowik, PhD, Vice President of the European Society for Molecular Imaging, Leiden University Medical Center, Netherlands
Timothy McCarthy, PhD, President of the Academy of Molecular Imaging, Pfizer Global R&D, Groton, CT
Chrit Moonen, PhD, Immediate Past President of the Society for Molecular Imaging, Universite Victor Segalen Bordeaux, France

Program Committee Members

Program Committee Chair
Paula Foster, PhD, Robarts Research Institute, London, ON

Disease/Organ Processes Emphasis
Win-Ping Deng, PhD, Taipei Medical University, Taiwan
Zahi Fayad, PhD, Mount Sinai School of Medicine, New York, NY

In Vivo Studies Emphasis
June-Key Chung, MD, PhD, Seoul National University Hospital, Korea
Adriana Maggi, PhD, University of Milan, Italy

Methodology & Instrumentation Emphasis
Simon Cherry, PhD, University of California, Davis, CA
Vasilis Ntziachristos, PhD, Technical University of Munich, Germany

Molecular & Cellular Processes Emphasis
Ali Arbab, PhD, MD, Henry Ford Health System, Detroit, MI
Yasuyoshi Watanabe, PhD, MD, RIKEN, Kobe, Japan

Probes Emphasis
William Eckelman, PhD, Molecular Tracer, LLC, Bethesda, MD
Michal Neeman, PhD, Weizmann Institute of Science, Israel

Therapy Emphasis
Jeffery Evelhoch, PhD, Merck Research Laboratories, West Point, PA
Michael Tweedle, PhD, Ohio State University, Columbus, OH

Educational Workshop Organizers
Bernd Pichler, PhD, University of Tuebingen, Germany
Fabian Kiessling, PhD, Aachen University, Germany

MOLECULAR IMAGING & ANALYSIS WORKSHOP The potential that Molecular Imaging has on drug development and healthcare outcomes is well recognized. The workshop will explore: The multiple modalities available in preclinical and clinical arenas Addressing the future of bioimaging as well as imaging biomarkers The translational challenges across therapeutic areas The differences and issues with Imaging identified across the continuum from research to clinical The technologies available and in design that will help manage the mounds of data that must be converted to solid, understandable information  KEYNOTE Dr. Jeffrey L. Evelhoch is vice president, Early Stage Development and head, Imaging at Merck Research Laboratories (MRL).  In this role Jeff, provides leadership and coordination for the use of Preclinical and Clinical Imaging resources for all MRL franchises and functions.  He ensures that imaging biomarkers are used optimally in the Target through IIB space and in late stage development to help advance Merck's compounds through to registration.  Dr. Evelhoch joined Merck in 2008, after four years at Amgen as executive director, Medical Sciences and head, Imaging Sciences.  He also worked at Pfizer Global Research & Development and Pharmacia Corporation and was on the faculty of Wayne State University School of Medicine for 18 years, where he was a professor of Internal Medicine, Radiology and Cancer Biology.  Dr. Evelhoch was named a Fellow of the International Society of Magnetic Resonance in Medicine (ISMRM) in 2003.  He is actively involved in the joint efforts of professional organizations, industry groups and federal agencies to further the development and use of quantitative imaging, including The Biomarker Consortium, the Quantitative Imaging Biomarker Alliance and the ISMRM Ad Hoc Committee on Standards for Quantitative Magnetic Resonance.  Dr. Evelhoch has a B.S. in chemistry from West Chester University and received his Ph.D. and M.S. in analytical chemistry from the University of California at Riverside.  He was also a postdoctoral fellow at Washington University in St. Louis. Throughout his career, he has actively published and served on National Institutes of Health review committees; he is currently a member of the National Cancer Institute's Experimental Therapeutics (NExT) Special Emphasis Panel.  DATE: April 26, 2010 TIME: 9:00AM-4:00PM LOCATION: Normandy Farm, Blue Bell, PA INCLUDES: Continental Breakfast, Lunch & Networking Reception Speakers Representing: University of Pennsylvania School of Medicine Merck GE Healthcare GSK NETWORKING PARTY You are all invited! Face to Face Networking- an old concept that works! Join us from 5:00-6:30pm Monday, April 26th Normandy Farm, Blue Bell, PA Free for attendees of both the Molecular Imaging Workshop & Career Transitions. $10 for all others. Networking proceeds donated to the Kortney Rose Foundation benefitting the Children's Hospital of Philadelphia. Learn more about our Career WorkshopTools for Transition: Evolving Beyond the Lab This special one-day workshop will be held in conjunction with the Molecular Imaging & Analysis Event. The BioPharma Research Council is a non-profit association formed in early January 2010. Our objective is to provide educational resources to the scientific community. We believe that scientific discourse and debate is central to the research and development process and yet many organizations have had to slash their travel and professional development budgets. We hope to fill the void left by budget cuts, and provide a local forum for NJ and PA scientists to meet and share ideas on a broad variety of topics affecting the BioPharma industry.

Postdoctoral Fellowship Opportunity, PhD/or MD, Molecular Imaging

UCLA SOMI

The UCLA Scholars in Oncologic Molecular Imaging (SOMI) Program is a unique postdoctoral training program for biological researchers and physicians who desire to integrate molecular imaging and cancer research. Molecular imaging provides powerful and sensitive tools to observe and measure the molecules, molecular processes, and events that distinguish malignant from normal tissues. Oncologic molecular imaging combines the disciplines of cellular and molecular biology, chemistry, physics, biomathematics and bioinformatics, pharmacology, imaging sciences, and clinical medicine to advance cancer research, diagnosis, and management.

Postdoctoral fellows, with backgrounds from across the basic sciences and medicine, will participate in an integrated, cross-disciplinary training program under the mentorship of a diverse group of basic science and clinical faculty members representing 7 departments and 6 divisions in the David Geffen School of Medicine, the College of Letters and Sciences, and the Henry Samueli School of Engineering and Applied Science. The centerpiece of the program is the opportunity to conduct innovative molecular imaging research co-mentored by two faculty members from complementary disciplines. Fellows also engage in specialized coursework, seminars, and a clinical tutorial program. Graduates of SOMI will be uniquely trained to lead research programs to study cancer in an organismal context with state-of-the-art technologies.

Support is provided for salary, supplies and travel, for up to three years. Applicants must hold a Ph.D. or M.D. degree and must be either a US citizen or permanent resident. Minority candidates are encouraged to apply.

Contact:

Erika Corrin
Crump Institute for Molecular Imaging
UCLA
570 Westwood Plaza
Los Angeles, CA 90095-1770
campus mail code: 177010
phone: (310) 825-4903
fax: (310) 206-8975
email: ecorrin@mednet.ucla.edu

Imaging 2020 VI: Imaging Biopathways
September 13-17, 2009

Jackson Hole, Wyoming

imagingin2010.com

Future medical therapies will increasingly focus on interrupting and redirecting pathologic biopathways at the genetic and cellular level. Imaging – especially molecular imaging - will play an indispensible role in the understanding of biopathways, the creation of biospecific interventions, and the monitoring and control of new, highly potent interventions.

Future imaging will require significantly greater sensitivity, specificity and quantitative robustness than exists today. The most significant evolution and greatest challenge will be increasing the specificity. To fully integrate imaging into therapeutics and diagnosis, imaging will need to be applicable to screening and interrogating therapeutically useful biopathways. Sessions have been designed around these themes. Discussions will address future advances in engineering and imaging modalities from NIR to X ray, microscopic in vivo imaging, fundamental advances in important biopathways (angiogenesis, metastasis, invasion and resistance, neurodegeneration, et al.), and the future roles of chemistry in imaging.

Key to meeting the challenges inherent in a complex future is open and effective communication among basic and clinical researchers from a wide spectrum of relevant disciplines. The goal of Imaging in 2020 is to catalyze this communication by laying the technical foundation for it, and by providing a format that is intentionally less structured than the traditional scientific meeting, allowing for extensive, meaningful interactions in a casual, comfortable environment. We hope to foster the development of enduring associations that will lead to innovative solutions and applications.

Imaging in 2020 VI will be held at the Jackson Lake Lodge in Jackson Hole, Wyoming. Its beautiful location in Grand Teton National Forest is easily accessible from Jackson Airport. Breathtaking views of the Grand Tetons provide a colorful backdrop to the meeting. Participants will have the opportunity during the unscheduled afternoons to enjoy a variety of outdoor activities, such as hiking, fishing, boating, horseback riding, or just relaxing in a truly spectacular natural setting.

Sunday, September 13
4:00 - 6:00 pm	Registration and Poster Set-up
6:00 - 7:00 pm	Dinner
7:00 - 7:15 pm	Welcome	Mike Tweedle
7:15 - 9:00 pm	Session I: Engineering
7:15 - 7:30 pm	Session Remarks (1999)	Tom Budinger (Moderator)
7:30 - 8:15 pm	Hardware, Miniaturization, Microfluidics	Greg Auner
8:15 - 9:00 pm	The Future of Today's Modalities	John Gore
9:00 - 10:00 pm	Reception and Poster Session
Monday, September 14
7:00 - 8:00 am	Breakfast
8:00 - 9:45 am	Session II: Chemistry I
8:00 - 8:15 am	Session Remarks (1999)	Mike Tweedle (Moderator)
8:15 - 9:00 am	Supramolecular Chemistry	Akira Harada
9:00 - 9:45 am	Multimodality Imaging Agents	Angelique Louie
9:45 - 10:00 am	Break
10:00 - 12:15 pm	Session III: Biopathways I
10:00 - 10:45 am	Session Remarks/Angiogenesis Pathology	Don McDonald
10:45 - 11:30 am	MRI Angiogenesis	Michal Neeman
11:30 - 12:15 pm	PET Angiogenesis	Markus Schwaiger
12:15 - 1:15 pm	Lunch
1:15 - 6:00 pm	Afternoon free time
6:00 - 7:00 pm	Dinner
7:15 - 8:45 pm	Session IV: Biopathways II
7:00 - 7:15 pm	Session Remarks (2003)	Adrian Nunn (Moderator)
7:15 - 8:00 pm	Metatases & Cell Motility	John Condeelis
8:00 - 8:45 pm	Cancer Invasion and Resistance	Peter Friedl
8:45 - 10:00 pm	Reception and Poster Session
Tuesday, September 15
7:00 - 8:00 am	Breakfast
8:00 - 9:45 am	Session V: Chemistry II
8:00 - 8:15 am	Session Remarks (1999)	Tom Meade (Moderator)
8:15 - 9:00 am	Topic TBD	Brian Hoffman
9:00 - 9:45 am	Topic TBD	Ken Raymond
9:45 - 10:15 am	Group Photo, Break
10:15 - 12:00 pm	Session VI: Pharmaceuticals
10:15 - 10:30 am	Session Remarks	Bradford Navia (Moderator)
10:30 - 11:15 am	Neurodegenerative Disease	Dan Silverman
11:15 - 12:00 pm	Imaging Biomarkers in Cancer	Michael Smith
12:00 - 12:45 pm	Lunch
12:45 - 6:00 pm	Afternoon free time/Bus trip into Jackson Hole
6:00 - 6:45 pm	Reception
6:45 - 7:45 pm	Dinner
7:45 - 7:55 pm	Introduction of Keynote Speaker	Bonnie Sloane
7:55 - 8:55 pm	Keynote Address	Roger Tsien 2008 Nobel Prizewinner for Chemistry
Wednesday, September 16
7:00 - 8:00 am	Breakfast
8:00 - 9:45 am	Sessoin VII: Ultrasound Agents
8:00 - 8:15 am	Session Remarks (1999)	Kathy Ferrara (Moderator)
8:15 - 9:00 am	Targeted Ultrasound Agents	Sasha Klibanov
9:00 - 9:45 am	Advances in Technology for Ultrasound Contrast Imaging	Paul Dayton
9:45 - 10:00 am	Break
10:00 - 11:45 am	Session VIII: Microscopy
10:00 - 10:15 am	Session Remarks	Bob Gillies (Moderator)
10:15 - 11:00 am	Endoscopic Microscopy	Rebecca Richards-Kortum
11:00 - 11:45 am	Microscopy with Gallium Ions	Sriram Subramaniam
11:45 - 12:30 pm	Lunch
12:45 - 6:00 pm	Afternoon free time
6:00 - 7:00 pm	Dinner
7:00 - 8:45 pm	Session IX: Animal Models
7:00 - 7:15 pm	Session Remarks (1999)	Dan Sullivan (Moderator)
7:15 - 8:00 pm	Animal Model Development	Terry Van Dyke
8:00 - 8:45 pm	Animal Models for Optical Imaging	David Kirsch
8:45 - 10:00 pm	Reception and Poster Session
Thursday, September 17
7:00 - 8:00 am	Breakfast
8:00 - 10:15 am	Session X: Imaging Biologicals
8:00 - 8:15 am	Session Remarks	Sarah Nelson (Moderator)
8:15 - 9:00 am	Cell Imaging In Vivo	Joe Frank
9:00 - 9:45 am	Imaging Enzymes	Matthew Bogyo
9:45 - 10:15 am	Meeting Summary & Concluding Remarks	Bonnie Sloane, Mike Tweedle

2009 World Molecular Imaging Congress

September 23-26, 2009 Montreal, Canada

wmicmeeting

WELCOME

It is with great pleasure that we invite you to participate in the upcoming 2009 World Molecular Imaging Congress (WMIC). Organizers from the Academy of Molecular Imaging (AMI), the Society for Molecular Imaging (SMI), the European Society for Molecular Imaging (ESMI), and the Federation of Asian Societies for Molecular Imaging (FASMI) are working together, with input from a scientifically diverse, international program committee, to develop a scientific program which integrates developments in imaging technologies and molecular imaging agents with applications for drug development, basic science investigations, and clinical translation.

The WMIC 2009 program will be constructed primarily on the strength of submitted abstracts. Continuing in the style of last year’s meeting, the Program committee will be integrating many of these abstracts into special sessions that bring attendees from different disciplines together for a comprehensive examination of the role of molecular imaging in particular biomedical problems.

An Excellent Meeting Venue – Montreal, Canada

The joie de vivre and warm hospitality of Montreal is legendary and just a few of the reasons why this city holds so much appeal for attendees from around the globe. The Palais des Congres de Montreal is the perfect size for our meeting. Exhibits will be right next to the educational meeting space and posters.

One-Stop Molecular Imaging Educational Technology Showcase

Industry exhibits will include the latest advances in pre-clinical and clinical imaging applications to create a "one-stop" molecular imaging educational technology showcase. The WMIC will bring together technically distinct and separate research communities that have a shared vision in the molecular imaging sciences. Building on the success of the first World Molecular Imaging Congress in Nice, we expect the attendance for the 2009 WMIC to exceed 2,000 participants from around the globe.